Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000127868 | SCV000171451 | benign | not specified | 2013-11-11 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Prevention |
RCV000127868 | SCV000311095 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Labcorp Genetics |
RCV002055786 | SCV002347177 | benign | Progressive myoclonic epilepsy | 2025-02-04 | criteria provided, single submitter | clinical testing | |
Unidad de Genómica Garrahan, |
RCV000127868 | SCV005087891 | benign | not specified | 2024-07-15 | criteria provided, single submitter | clinical testing | This variant is classified as Benign based on local population frequency. This variant was detected in 30% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy and Progressive Myoclonus Epilepsy. Number of patients: 28. Only high quality variants are reported. |
Breakthrough Genomics, |
RCV004715736 | SCV005298003 | benign | not provided | criteria provided, single submitter | not provided |